Scavenger receptor AI/II truncation, lung function and COPD: A large population-based study

Journal of Internal Medicine

Volumn 269, Issue 3, 2011, Pages 340-348

  Thomsen, M ^a,b   Nordestgaard, B G ^a,b,c   Tybjaerg Hansen A ^b,c,d   Dahl, M ^a,b,d  

^a Department of Clinical Biochemistry ^*  (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d Rigshospitalet   (Denmark)

Author keywords

Alpha 1 antitrypsin; Chronic obstructive pulmonary disease; Genetics

Indexed keywords

ARGININE; SCAVENGER RECEPTOR A; SCAVENGER RECEPTOR A1; SCAVENGER RECEPTOR A2; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FEMALE; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; LUNG ALVEOLUS MACROPHAGE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SEX DIFFERENCE; VITAL CAPACITY;

ADULT; AGED; COHORT STUDIES; DENMARK; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HETEROZYGOTE; HUMANS; LUNG; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SCAVENGER RECEPTORS, CLASS A; SEX FACTORS; VITAL CAPACITY;

EID: 79951702400     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2010.02308.x     Document Type: Article

References (30)

1. Rabe KF, Hurd S, Anzueto A et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-55.
2. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet 2007; 370: 765-73.
3. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160(5 pt 2): S29-32.
4. Sulahian TH, Imrich A, Deloid G, Winkler AR, Kobzik L. Signaling pathways required for macrophage scavenger receptor-mediated phagocytosis: analysis by scanning cytometry. Respir Res 2008; 9: 59.
5. Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S. Macrophage receptors and immune recognition. Annu Rev Immunol 2005; 23: 901-44.
6. Greaves DR, Gordon S. The macrophage scavenger receptor at 30years of age: current knowledge and future challenges. J Lipid Res 2009; 50 (Suppl): S282-6.
7. Ohar JA, Hamilton Jr. RF, Zheng S et al. COPD is associated with a Macrophage Scavenger Receptor (MSR1) gene sequence variation. Chest 2010; 137: 1098-107.
8. Palmer LJ, Celedon JC, Chapman HA, Speizer FE, Weiss ST, Silverman EK. Genome-wide linkage analysis of bronchodilator responsiveness and post-bronchodilator spirometric phenotypes in chronic obstructive pulmonary disease. Hum Mol Genet 2003; 12: 1199-210.
9. Hersh CP, DeMeo DL, Raby BA et al. Genetic linkage and association analysis of COPD-related traits on chromosome 8p. COPD 2006; 3: 189-94.
10. Kirkham PA, Spooner G, Ffoulkes-Jones C, Calvez R. Cigarette smoke triggers macrophage adhesion and activation: role of lipid peroxidation products and scavenger receptor. Free Radic Biol Med 2003; 35: 697-710.
11. Dejager S, Mietus-Snyder M, Friera A, Pitas RE. Dominant negative mutations of the scavenger receptor. Native receptor inactivation by expression of truncated variants. J Clin Invest 1993; 92: 894-902.
12. Doi T, Higashino K, Kurihara Y et al. Charged collagen structure mediates the recognition of negatively charged macromolecules by macrophage scavenger receptors. J Biol Chem 1993; 268: 2126-33.
13. Xu J, Zheng SL, Komiya A et al. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat Genet 2002; 32: 321-5.
14. Dahl M, Tybjaerg-Hansen A, Lange P, Vestbo J, Nordestgaard BG. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: a longitudinal study of the general population. Ann Intern Med 2002; 136: 270-9.
15. Dahl M, Bowler RP, Juul K, Crapo JD, Levy S, Nordestgaard BG. Superoxide dismutase 3 polymorphism associated with reduced lung function in two large populations. Am J Respir Crit Care Med 2008; 178: 906-12.
16. Baekvad-Hansen M, Dahl M, Tybjaerg-Hansen A, Nordestgaard BG. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers. Am J Respir Crit Care Med 2010; 181: 17-20.
17. Dahl M, Nordestgaard BG, Lange P, Tybjaerg-Hansen A. Fifteen-year follow-up of pulmonary function in individuals heterozygous for the cystic fibrosis phenylalanine-508 deletion. J Allergy Clin Immunol 2001; 107: 818-23.
18. Fujita Y, Kakino A, Harada-Shiba M, Sato Y, Otsui K, Yoshimoto R et al. C-reactive protein uptake by macrophage cell line via class-A scavenger receptor. Clin Chem 2010; 56:478-81.
19. Kuronuma K, Sano H, Kato K et al. Pulmonary surfactant protein A augments the phagocytosis of Streptococcus pneumoniae by alveolar macrophages through a casein kinase 2-dependent increase of cell surface localization of scavenger receptor A. J Biol Chem 2004; 279: 21421-30.
20. Acton S, Resnick D, Freeman M, Ekkel Y, Ashkenas J, Krieger M. The collagenous domains of macrophage scavenger receptors and complement component C1q mediate their similar, but not identical, binding specificities for polyanionic ligands. J Biol Chem 1993; 268: 3530-7.
21. Leyva FJ, Pershouse MA, Holian A. Modified low density lipoproteins binding requires a lysine cluster region in the murine macrophage scavenger receptor class A type II. Mol Biol Rep 2010; 37: 2847-52
22. Andersson L, Freeman MW. Functional changes in scavenger receptor binding conformation are induced by charge mutants spanning the entire collagen domain. J Biol Chem 1998; 273: 19592-601.
23. Murphy JE, Tedbury PR, Homer-Vanniasinkam S, Walker JH, Ponnambalam S. Biochemistry and cell biology of mammalian scavenger receptors. Atherosclerosis 2005; 182: 1-15.
24. Tanaka T, Nishikawa A, Tanaka Y et al. Synthetic collagen-like domain derived from the macrophage scavenger receptor binds acetylated low-density lipoprotein in vitro. Protein Eng 1996; 9: 307-13.
25. Arredouani MS, Yang Z, Imrich A, Ning Y, Qin G, Kobzik L. The macrophage scavenger receptor SR-AI/II and lung defense against pneumococci and particles. Am J Respir Cell Mol Biol 2006; 35: 474-8.
26. Dahl M, Bauer AK, Arredouani M et al. Protection against inhaled oxidants through scavenging of oxidized lipids by macrophage receptors MARCO and SR-AI/II. J Clin Invest 2007; 117: 757-64.
27. Kobayashi H, Sakashita N, Okuma T et al. Class A scavenger receptor (CD204) attenuates hyperoxia-induced lung injury by reducing oxidative stress. J Pathol 2007; 212: 38-46.
28. Moore KJ, Kunjathoor VV, Koehn SL et al. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest 2005; 115: 2192-201.
29. Chao TC, Phuangsab A, Van Alten PJ, Walter RJ. Steroid sex hormones and macrophage function: regulation of chemiluminescence and phagocytosis. Am J Reprod Immunol 1996; 35: 106-13.
30. Arredouani MS, Palecanda A, Koziel H et al. MARCO is the major binding receptor for unopsonized particles and bacteria on human alveolar macrophages. J Immunol 2005; 175: 6058-64.